USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

Contrib Nephrol. 1989;76:160-5; discussion 212-8. doi: 10.1159/000417892.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Anemia / blood
  • Anemia / complications
  • Anemia / drug therapy
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use*
  • Humans
  • Hypertension / etiology
  • Iron / blood
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Multicenter Studies as Topic
  • Renal Dialysis*
  • Seizures / etiology
  • United States

Substances

  • Erythropoietin
  • Iron